The ABCs of asthma control

Mayo Clinic Proceedings

Volumn 83, Issue 7, 2008, Pages 814-820

  Thorsteinsdottir, Bjorg ^a,c   Volcheck, Gerald W ^a   Madsen, Bo Enemark ^b,d   Patel, Ashokakumar M ^a   Li, James T C ^a   Lim, Kaiser G ^a  

^a MAYO CLINIC   (United States)

^b Department of Emergency Medicine ^*  (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PIRBUTEROL ACETATE; SALBUTAMOL;

ASTHMA; CLINICAL DECISION MAKING; CLINICAL PRACTICE; COMORBIDITY; DISEASE CONTROL; DISEASE SEVERITY; HEALTH CARE PERSONNEL; HUMAN; IMMUNOTHERAPY; LUNG FUNCTION; OUTCOME ASSESSMENT; PATIENT EDUCATION; PATIENT MONITORING; QUESTIONNAIRE; REVIEW; RISK ASSESSMENT;

EID: 46749099346     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/83.7.814     Document Type: Review

References (61)

1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Updated 2007. Global Initiative for Asthma Web site. http://www.ginasthma.org. Accessed May 20, 2008.
2. National Heart Lung and Blood Institute. National Asthma Education and Prevention Program Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health. NIH Publication 08-4051. http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm. Accessed May 20, 2008.
3. Cockcroft DW, Swystun VA. Asthma control versus asthma severity. J Allergy Clin Immunol. 1996;98(6, pt 1):1016-1018.
4. Bateman ED, Boushey HA, Bousquet J, et al, GOAL Investigators Group. Can guideline-defined asthma control be achieved? the Gaining Optimal Asthma ControL Study. Am J Respir Crit Care Med. 2004 Oct 15;170(8):836-844. Epub 2004 Jul 15.
5. Vollmer WM, Markson LE, O'Connor E, Frazier EA, Berger M, Buist AS. Association of asthma control with health care utilization: a prospective evaluation. Am J Respir Crit Care Med. 2002;165(2):195-199.
6. Vollmer WM, Markson LE, O'Connor E, et al. Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med. 1999;160(5, pt 1):1647-1652.
7. Li JT, Oppenheimer J, Bernstein IL, Nicklas RA, Joint Task Force on Practice Parameters. Attaining optimal asthma control: a practice parameter [published correction appears in J Allergy Clin Immunol. 2006;117(2):262]. J Allergy Clin Immunol. 2005;116(5):S3-S11.
8. Wolfenden LL, Diette GB, Krishnan JA, Skinner EA, Steinwachs DM, Wu AW. Lower physician estimate of underlying asthma severity leads to undertreatment. Arch Intern Med. 2003;163(2):231-236.
9. Matsui EC. Lower physician estimate of underlying asthma severity leads to undertreatment. Pediatrics. 2004;114:534. doi:10.1542/peds.114.2.S1. 534.
10. Yawn BP, Brenneman SK, Allen-Ramey FC, Cabana MD, Markson LE. Assessment of asthma severity and asthma control in children. Pediatrics. 2006;118(1):322-329.
11. Halterman JS, Yoos HL, Kaczorowski JM, et al. Providers underestimate symptom severity among urban children with asthma. Arch Pediatr Adolesc Med. 2002;156(2):141-146.
12. McCoy K, Shade DM, Irvin CG, American Lung Association Asthma Clinical Research Centers. Predicting episodes of poor asthma control in treated patients with asthma. J Allergy Clin Immunol. 2006 Dec;118(6):1226-1233. Epub 2006 Oct 23.
13. Juniper EF, Bousquet J, Abetz L, Bateman ED GOAL Committee. Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. Respir Med. 2006 Apr;100(4):616-621. Epub 2005 Oct 13.
14. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the Asthma Control Test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59-65.
15. Skinner EA, Diette GB, Algatt-Bergstrom PJ, et al. The Asthma Therapy Assessment Questionnaire (ATAQ) for children and adolescents. Dis Manag. 2004 Winter;7(4):305-313.
16. Laforest L, Van Ganse E, Devouassoux G, et al. Management of asthma in patients supervised by primary care physicians or by specialists. Eur Respir J. 2006;27(1):42-50.
17. Schatz M, Sorkness CA, Li JT, et al. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol. 2006;117(3):549-556.
18. Markson LE, Vollmer WM, Fitterman L, et al. Insight into patient dissatisfaction with asthma treatment. Arch Intern Med. 2001;161(3):379-384.
19. Banzett RB, Dempsey JA, O'Donnell DE, Wamboldt MZ. Symptom perception and respiratory sensation in asthma. Am J Respir Crit Care Med. 2000;162(3, pt 1):1178-1182.
20. Lemanske RF Jr, Robert F., Busse WW. Asthma: factors underlying inception, exacerbation, and disease progression. J Allergy Clin Immunol. 2006;117(2 suppl Mini-Primer):S456-S461.
21. Rank MA, Li JT. Allergen immunotherapy. Mayo Clin Proc. 2007;82(9):1119-1123.
22. D'Amato G. Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases. Eur J Pharmacol. 2006 Mar 8;533(1-3):302-307. Epub 2006 Feb 7.
23. Schaffer SD, Tian L. Promoting adherence: effects of theory-based asthma education. Clin Nurs Res. 2004;13(1):69-89.
24. Allen SC, Ragab S. Ability to learn inhaler technique in relation to cognitive scores and tests of praxis in old age. Postgrad Med J. 2002;78(915):37-39.
25. Katsara M, Donnelly D, Iqbal S, Elliot T, Everard ML. Relationship between exhaled nitric oxide levels and compliance with inhaled cortico-steroids in asthmatic children. Respir Med. 2006 Sep;100(9):1512-1517. Epub 2006 Feb 28.
26. Beck-Ripp J, Griese M, Arenz S, Koring C, Pasqualoni B, Bufler P. Changes of exhaled nitric oxide during steroid treatment of childhood asthma. Eur Respir J. 2002;19(6):1015-1019.
27. O'Byrne PM, Parameswaran K. Pharmacological management of mild or moderate persistent asthma. Lancet. 2006;368(9537):794-803.
28. Sin DD, Man J, Sharpe H, Gan WQ, Man SF. Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis. JAMA. 2004;292(3):367-376.
29. Rolla G, Guida G, Heffler E, et al. Diagnostic classification of persistent rhinitis and its relationship to exhaled nitric oxide and asthma: a clinical study of a consecutive series of patients. Chest. 2007 May;131(5):1345-1352. Epub 2007 Feb 22.
30. Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg. 2003;129(3 suppl):S1-S32.
31. ten Brinke A, Sterk PJ, Masclee AA, et al. Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J. 2005;26(5):812-818.
32. Bousquet J, van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(5)(suppl):S147-S334.
33. Aggarwal R, Cardozo A, Homer JJ. The assessment of topical nasal drug distribution. Clin Otolaryngol Allied Sci. 2004;29(3):201-205.
34. Anderson SD, Daviskas E. The mechanism of exercise-induced asthma is .... J Allergy Clin Immunol. 2000;106(3):453-459.
35. Greiling AK, Boss LP, Wheeler LS. A preliminary investigation of asthma mortality in schools. J Sch Health. 2005;75(8):286-290.
36. Chaudhuri R, McSharry C, McCoard A, et al. Role of symptoms and lung function in determining asthma control in smokers with asthma. Allergy. 2008;63(1):132-135.
37. Chaudhuri R, Livingston E, McMahon AD, et al. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med. 2006 Jul 15;174(2):127-133. Epub 2006 Apr 27.
38. Lazarus SC, Chinchilli VM, Rollings NJ, et al, National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med. 2007Apr 15;175(8):783-790. Epub 2007 Jan 4.
39. Banks D, Jalloul A. Occupational asthma, work-related asthma and reactive airways dysfunction syndrome. Curr Opin Pulm Med. 2007;13(2):131-136.
40. Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med. 2007 Apr 1;175(7):661-666. Epub 2007 Jan 18.
41. Rodrigo GJ, Plaza V. Body mass index and response to emergency department treatment in adults with severe asthma exacerbations: a prospective cohort study. Chest. 2007 Nov;132(5):1513-1519. Epub 2007 Sep 21.
42. McLachlan C, Poulton R, Car G, et al. Adiposity, asthma, and airway inflammation. J Allergy Clin Immunol. 2007 Mar;119(3):634-639. Epub 2006 Dec 4.
43. Ciftci TU, Ciftci B, Guven SF, Kokturk O, Turktas H. Effect of nasal continuous positive airway pressure in uncontrolled nocturnal asthmatic patients with obstructive sleep apnea syndrome. Respir Med. 2005 May;99 (5):529-534. Epub 2004 Nov 23.
44. Havemann B, Henderson CA, El-Serag HB. The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut. 2007 Dec;56(12):1654-1664. Epub 2007 Aug 6.
45. Littner MR, Leung FW, Ballard ED II, Huang B, Samra NK, Lansoprazole Asthma Study Group. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest. 2005;128(3):1128- 1135.
46. Harding SM, Guzzo MR, Richter JE. 24-h esophageal pH testing in asthmatics: respiratory symptom correlation with esophageal acid events. Chest. 1999;115(3):654-659.
47. Kiljander TO, Harding SM, Field SK, et al. Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial. Am J Respir Crit Care Med. 2006 May 15;173(10):1091-1097. Epub 2005 Dec 15.
48. van den Berg NJ, Hagmolen of ten Have W, Nagelkerke AF, Bindels PJE, van der Palen J, van Aalderen WMC. What general practitioners and paediatricians think about their patients' asthma. Patient Educ Couns. 2005 Nov; 59(2):182-185. Epub 2004 Dec 16.
49. Douma WR, Kerstjens HA, Rooyackers JM, Koëter GH, Postma DS, Dutch CNSLD Study Group. Risk of overtreatment with current peak flow criteria in self-management plans. Eur Respir J. 1998;12(4):848-852.
50. Reddel HK, Barnes DJ Exacerbation Advisory Panel. Pharmacological strategies for self-management of asthma exacerbations. Eur Respir J. 2006;28(1):182-199.
51. Gibson PG, Powell H. Written action plans for asthma: an evidence-based review of the key components. Thorax. 2004;59(2):94-99.
52. Reddel HK, Marks GB, Jenkins CR. When can personal best peak flow be determined for asthma action plans? Thorax. 2004;59(11):922-924.
53. Lefevre F, Piper M, Weiss K, Mark D, Clark N, Aronson N. Do written action plans improve patient outcomes in asthma? an evidence-based analysis. J Fam Pract. 2002;51(10):842-848.
54. Clark NM, Gong M. Management of chronic disease by practitioners and patients: are we teaching the wrong things? BMJ. 2000;320(7234):572-575.
55. Gibson PG, Powell H, Coughlan J, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev. 2002;3:CDC001117.
56. Yawn BP, Wollan PC, Bertram SL, et al. Asthma treatment in a population-based cohort: putting step-up and step-down treatment changes in context. Mayo Clin Proc. 2007;82(4):414-421.
57. Bacharier LB. "Step-down" therapy for asthma: why, when, and how [editorial]? J Allergy Clin Immunol. 2002;109(6):916-919.
58. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med. 2005 May 26;352(21):2163-2173. Epub 2005 May 24.
59. Tonelli M, Bacci E, Dente FL, et al. Predictors of symptom recurrence after low-dose inhaled corticosteroid cessation in mild persistent asthma. Respir Med. 2006 Apr;100(4):622-629. Epub 2005 Oct 25.
60. Giannini D, Di Franco A, Cianchetti S, et al. Analysis of induced sputum before and after withdrawal of treatment with inhaled corticosteroids in asthmatic patients. Clin Exp Allergy. 2000;30(12):1777-1784.
61. American Lung Association Asthma Clinical Research Centers. Randomized comparison of strategies for reducing treatment in mild persistent asthma [published correction appears in N Engl J Med. 2007;357(7):728]. N Engl J Med. 2007;356(20):2027-2039.